EOLS

EVOLUS, INC.

Company Overview

Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market Cap$612.4M
Employees353
CEODavid Moatazedi

Valuation

Current Price$9.3
Fair Value?$000.00
Valuation?No valuation
Hist. PE ?N/A
EPS (TTM) ?-0.52
Forward EPS Growth ?
Historical Growth ?15.01%
Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro

Price

EPS

Revenue

Equity

Pro

Available on the Pro plan

Free Cash Flow

Pro

Available on the Pro plan

Long Term Debt

Pro

Available on the Pro plan

Net Profit

Pro

Available on the Pro plan

Shares Outstanding

Pro

Available on the Pro plan

Last updated: 9/5/2026, 6:14:47 PM